BETA: Please send your feedback!
Vanda Pharmaceuticals
VNDA:NAS
Biotechnology
$0
SMALL cap
$13.63
(0.04%)
-0.49%
since start of 2019
25.26
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- 1
-
CF
-
PP
-
WC
-
DP
-
CH
-
ES
-
WS
-
CG
-
EP
-
CM
-
FL
-
GD
- —
- 1
- 2
- 3
- 4
- 5
About
Biotechnology
Founded 2002
Vanda Pharmaceuticals, Inc. is a global biopharmaceutical company, which focuses on the development and commercialization of innovative therapies to improve the lives of patients. It intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.
website
Headquarters
Executives
| Name | Title | Gender |
| H. Thomas Watkins, MBA | Chairman | Male |
| Chip Clark, MBA | Founder | Male |
| Argeris N. Karabelas, PhD | Founder | Male |
| Mihael Hristos Polymeropoulos, MD | President, Chief Executive Officer & Director | Male |
| James Patrick Kelly, CFA, MBA | Chief Financial Officer, Treasurer & Senior VP | Male |
| Richard L. Gulino | Secretary, Senior VP & General Counsel | Male |
Mindful Investing Summary
- —
- 1
- 2
- 3
- 4
- 5
-
Carbon Footprint — N/A
-
Pollution Prevention — N/A
-
Water Conservation — N/A
-
Data & Privacy Protection — N/A
-
Consumer Health, Wellness & Safety — N/A
-
Employee Ownership, Satisfaction, Benefits & Pay — N/A
-
Workplace Health and Safety — N/A
-
Integrity of Corporate Governance — N/A
-
Ethical Practices — N/A
-
Usage of Conflict Materials — N/A
-
Forced Labor — N/A
-
Diversity of Corporate Leadership 1
Vanda Pharmaceuticals - Competitors and Related Companies
How Vanda Pharmaceuticals stacks up to its peers in the Biotechnology industry or with competing business segments.
Vanda Pharmaceuticals
VNDA:NAS
Biotechnology
$0
SMALL cap
$13.63
(0.04%)
-0.49%
since start of 2019
25.26
Paratek Pharmaceuticals
PRTK:NAS
Biotechnology
$104.44mm
SMALL cap
$3.21
(-0.03%)
-0.43%
since start of 2019
-0.84
Titan Pharmaceuticals
TTNP:NAS
Biotechnology
$3.15mm
MICRO cap
$0.18
(0.01%)
-0.82%
since start of 2019
-0.21
Bristol-Myers Squibb
BMY:NYS
Pharmaceuticals: Major
$87.02bn
MEGA cap
$53.20
(0.17%)
0.01%
since start of 2019
13.96
Johnson & Johnson
JNJ:NYS
Pharmaceuticals: Major
$337.87bn
MEGA cap
$128.02
(0.32%)
0.00%
since start of 2019
—
Merck
MRK:NYS
Pharmaceuticals: Major
$216.40bn
MEGA cap
$84.52
(-0.16%)
0.12%
since start of 2019
23.49